publications
With Measles Roaring Back, the Search for a Drug is On
As vaccination rates decline, biotech companies see a potential new market for measles drugs.
Read full story on NY Times → More top storiesAlso covered by
Aggregated and edited by the Scoop newsroom. We surface news from NY Times alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop